Since Tau deposits in AD correlate with neurodegeneration and cognitive decline, the stereotypic spreading of Tau pathology from the transentorhinal regions to the neocortex is used for disease staging (Braak and Braak, 1995). This evidence concerns the gene MAPT and Alzheimer disease.